Stockchase Opinions

The Weekly Buzzing Stocks by Billy KawasakiPepsiCoPEPTOP PICKAug 10, 2023

PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated more than $67 billion in net revenue in 2019, driven by a complementary food and beverage portfolio that includes Frito-Lay, Gatorade, Pepsi-Cola, Quaker and Tropicana. PepsiCo's product portfolio includes a wide range of enjoyable foods and beverages, including 23 brands that generate more than $1 billion each in estimated annual retail sales. Guiding PepsiCo is our vision to Be the Global Leader in Convenient Foods and Beverages by Winning with Purpose. "Winning with Purpose" reflects our ambition to win sustainably in the marketplace and embed purpose into all aspects of the business. Social media mentions are up 170% in the past 24h.

$184.40

Stock price when the opinion was issued

$140.68

As of Jun 08, 2026. Market Open.

food processing
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY

They report Thursday. He's impressed by how they've dealt with the rise of GLP-1 drugs and healthy diets among the young. The CEO listens to customers.

COMMENT

 It reports Tuesday. He worries about it because of its snack division which has been struggling against the weight-loss drugs. Shares moved up today.

DON'T BUY

They report Thursday. They've had it tough lately, but have a strong Frito-Lay snack franchise. Also pays a solid 4% dividend. However, the younger generation is watching their health, and people are taking weight-loss drugs, GLP-1 which diminishes cravings. PEP is -7% this year vs. Coke +7%.

BUY

Pays a safe 4% yield. Shares are bottoming now. Own, don't trade.

BUY

Remains a premium growth company. Elliott Management just took a big stake, and he likes this activist firm. Shares are 7 points below before Elliott stepped in--a bargain. Also, this yields almost 4% because shares have fallen so much.

DON'T BUY

It reports Thursday. It trades at a low 17x PE. Headwinds: GLP-1 drugs, RFJ Jr. who despises junk food though embraces junk science, and the desire to stay healthy. It's a tough industry.

DON'T BUY

He sold in 2024 when the valuation started looking a bit full. When pandemic inflation hit, "elasticity" was low so that consumers kept buying despite higher prices. Cumulative effect of inflation caught up to them. Not tempted, given slowing macro economy and inflation genie not fully back in the bottle.

HOLD

Operates in a cola duopoly with KO, good job creating shareholder value. He likes market leaders like these that have little to no direct competition, so this name fits that bill. That being said, it's a lot harder these days with consumer brands to establish a brand and build a moat. Today he could launch a cola company online, using Instagram and FB, with very little cost and effort, and with luck it could even go viral. Brands will have a tough time. 

Very strong, well-established brand. PEP got into snacks, which are up against healthier lifestyles. He owns FEVR, take a look at that one.

DON'T BUY

An amazing company and major soft drinks maker. Shares are far from its last highs, so low that the dividend now pays 4.42%. Suppose RFK Jr. goes after companies that produce caloric snacks? Share are very undervalued, but who knows when shares will stop going down?

BUY

Yields 4%, well-run and can start a position at 16x PE. They will right the ship. 

COMMENT

Was just downgraded. The consumer is fed up with shrinking product, like potato chips per bag. Consumer products must take the hit and lower prices like this, which will shrink margins. But it's worth it as opposed to this shrinkage. 

BUY

Rallied 2.95% in today's sell-off as people sough safety in stocks that do well in a recession. Pays a 3% dividend.

DON'T BUY

Historic growth story of Pepsi was the Frito-Lay franchise. Not the growth company it was. Still trades at a reasonably high multiple for its growth rate. International sources of revenue, so the strong USD is a major headwind.

Companies in the snack space have traded off on the fears of GLP-1. Volumes are starting to drop. Growth metrics just don't support the valuations.

DON'T BUY

It reports Tuesday. The weight-loss drugs make it hard for PEP to thrive. It pays a 3.6% dividend, though.

DON'T BUY

GLP weight-loss drugs have hurt, and in some countries like India PEP has faced headwinds over their use of water, which is scarce is those places.